CCM
DVAX

Consonance Capital Management’s Dynavax Technologies DVAX Stock Holding History

Consonance Capital Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,658,795
Closed -$32.9M – 30
2018
Q1 		$32.9M Buy
+1,658,795
New +$28.6M 3.01% 13

Other funds holding DVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Consonance Capital Management's DVAX Position: Q2 2018 in Review

Consonance Capital Management sold out of Dynavax Technologies (DVAX) in Q2 2018, closing a stake of 1,658,795 shares — an estimated $32.9M sold.

Consonance Capital Management first reported a position in DVAX in Q1 2018 and held it in 1 quarter. The position peaked at $32.9M in Q1 2018. 155 funds tracked by Wall St. Rank hold DVAX as of Q2 2018.

  • Consonance Capital Management reported no remaining Dynavax Technologies position as of Q2 2018 after selling out during the quarter.
  • Consonance Capital Management sold 1,658,795 Dynavax Technologies shares in Q2 2018, an estimated $32.9M.
  • Consonance Capital Management first reported a position in Dynavax Technologies in Q1 2018 and held it in 1 quarter.
  • Consonance Capital Management's Dynavax Technologies position peaked at $32.9M in Q1 2018.
  • 155 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2018.

Based on Consonance Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.